Psychological Prehabilitation Boosts Patients' Postsurgical Outcomes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, March 25, 2025 -- Psychological prehabilitation may improve four postoperative outcomes: reduced length of stay (LOS), pain, anxiety, and depression, according to a review recently published online in the Annals of Surgery.
Ann E. Hall, from University of California Los Angeles, and colleagues conducted a systematic literature review, meta-analysis, and meta-regression to assess the effect of psychotherapy prehabilitation on the four postoperative outcomes of LOS, pain, anxiety, and depression.
Based on 20 included articles (2,376 patients), the researchers found that psychological prehabilitation interventions included cognitive behavioral therapy (70 percent), supportive psychotherapy (25 percent), and acceptance and commitment therapy (5 percent). In a pooled analysis, interventions were associated with greater reductions in LOS (mean difference [MD], −1.62 days), pain (MD, −3.52), anxiety (standard mean difference [SMD], −1.51), and depression (SMD, −1.48). With the exception of anxiety, there were no significant differences in results by psychotherapy modality and surgery type.
"While additional research is needed to assess the differential effects of varying modalities and methods of delivery, the integration of structured psychological interventions into preoperative care represents a promising avenue for improving surgical outcomes," the authors write. "Further studies are necessary to compare different types, duration, and delivery methods of psychotherapy for specific postoperative outcomes of interest."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-26 12:00
Read more

- ACC: Colorectal Cancer Tied to Higher Risk for Cardiovascular Death
- Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
- Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
- Five Top CDC Leaders Step Down Amid Wave of Departures
- High Levels of Perimenopause-Related Symptoms Seen in Younger Women
- Americans Borrowed $74 Million in 2024 to Cover Medical Costs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions